tiprankstipranks
Advertisement
Advertisement

IN:AUROPHARMA Stock Latest News

Aurobindo Pharma Board Clears ₹800-Crore Share Buyback via Tender Offer
Company AnnouncementsAurobindo Pharma Board Clears ₹800-Crore Share Buyback via Tender Offer
11d ago
Aurobindo Pharma Transfers Domestic Branded Generics Business to Subsidiary
PremiumCompany Announcements
Aurobindo Pharma Transfers Domestic Branded Generics Business to Subsidiary
11d ago
Aurobindo Pharma Clears ₹800-Crore Share Buyback at ₹1,475 a Share
PremiumCompany Announcements
Aurobindo Pharma Clears ₹800-Crore Share Buyback at ₹1,475 a Share
11d ago
Aurobindo Pharma Schedules Analyst and Investor Plant Visit to Vizag and Kakinada
PremiumCompany Announcements
Aurobindo Pharma Schedules Analyst and Investor Plant Visit to Vizag and Kakinada
1M ago
Aurobindo Pharma Schedules Analyst and Investor Plant Visit to Vizag and Kakinada
PremiumCompany Announcements
Aurobindo Pharma Schedules Analyst and Investor Plant Visit to Vizag and Kakinada
1M ago
Aurobindo Pharma to Join Goldman Sachs India Pharma Corporate Days Investor Meet
PremiumCompany AnnouncementsAurobindo Pharma to Join Goldman Sachs India Pharma Corporate Days Investor Meet
2M ago
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid MIP Notification on Key Antibiotics
Premium
Company Announcements
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid MIP Notification on Key Antibiotics
2M ago
Aurobindo Pharma Schedules Q3 FY26 Analyst and Investor Earnings Call
Premium
Company Announcements
Aurobindo Pharma Schedules Q3 FY26 Analyst and Investor Earnings Call
2M ago
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid Antibiotic MIP Move
PremiumCompany Announcements
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid Antibiotic MIP Move
3M ago
Aurobindo Pharma Says Surge in Share Volume Is Market Driven, Not Due to Undisclosed Events
PremiumCompany Announcements
Aurobindo Pharma Says Surge in Share Volume Is Market Driven, Not Due to Undisclosed Events
3M ago
Aurobindo’s CuraTeQ Wins Health Canada Nod for Dyrupeg Biosimilar
PremiumCompany Announcements
Aurobindo’s CuraTeQ Wins Health Canada Nod for Dyrupeg Biosimilar
3M ago
Aurobindo Pharma Shuts Trading Window Ahead of Q3 FY26 Results
PremiumCompany Announcements
Aurobindo Pharma Shuts Trading Window Ahead of Q3 FY26 Results
4M ago
Aurobindo Pharma Concludes US FDA Inspection with No Operational Impact
PremiumCompany AnnouncementsAurobindo Pharma Concludes US FDA Inspection with No Operational Impact
4M ago
Aurobindo Pharma Announces Key Senior Management Changes
Premium
Company Announcements
Aurobindo Pharma Announces Key Senior Management Changes
5M ago
Aurobindo Pharma Expands into Chilean Market with New Subsidiary
Premium
Company Announcements
Aurobindo Pharma Expands into Chilean Market with New Subsidiary
6M ago
Aurobindo Pharma Expands into Chile with New Subsidiary
PremiumCompany Announcements
Aurobindo Pharma Expands into Chile with New Subsidiary
6M ago
Aurobindo Pharma Expands into Malaysia with New Subsidiary
PremiumCompany Announcements
Aurobindo Pharma Expands into Malaysia with New Subsidiary
7M ago
Aurobindo Pharma’s Apitoria Unit Completes US FDA Inspection with Procedural Observations
PremiumCompany Announcements
Aurobindo Pharma’s Apitoria Unit Completes US FDA Inspection with Procedural Observations
8M ago
Aurobindo Pharma to Engage in Virtual Investor Conference
PremiumCompany Announcements
Aurobindo Pharma to Engage in Virtual Investor Conference
8M ago
CuraTeQ Biologics Gains EMA Positive Opinion for Dazublys®
PremiumCompany AnnouncementsCuraTeQ Biologics Gains EMA Positive Opinion for Dazublys®
12M ago
Aurobindo Pharma’s Eugia Pharma Gains USFDA Approval for Dasatinib Tablets
Premium
Company Announcements
Aurobindo Pharma’s Eugia Pharma Gains USFDA Approval for Dasatinib Tablets
12M ago
Aurobindo Pharma Secures USFDA Approval for Rivaroxaban Tablets
Premium
Company Announcements
Aurobindo Pharma Secures USFDA Approval for Rivaroxaban Tablets
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >